UTAH MEDICAL PRODUCTS INC (UTMD) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	34.9M	38.5M	40.9M	50.2M	52.3M
Cost of Revenue	14.8M	16.5M	16.8M	20.2M	20.1M
Gross Profit	20.1M	22.0M	24.1M	30.0M	32.2M
Operating Expenses
R&D Expense	662.0K	668.0K	813.0K	560.0K	493.0K
SG&A Expense	9.0M	9.9M	5.6M	12.7M	11.9M
General & Admin Expense	8.5M	7.9M	3.7M	11.0M	10.4M
Selling & Marketing Expense	529.0K	2.1M	1.9M	1.7M	1.5M
Other Expenses	—	—	4.2M	—	—
Total Operating Expenses	9.7M	10.6M	10.5M	13.3M	12.4M
Cost and Expenses	24.5M	27.1M	27.3M	33.4M	32.5M
Operating Income (EBIT)	10.4M	11.4M	13.6M	16.8M	19.8M
Non-Operating
Interest Income	631.0K	2.8M	3.4M	—	661.0K
Interest Expense	—	—	—	—	—
Net Interest Income	631.0K	2.8M	3.4M	—	661.0K
Other Non-Op Income/Expense	2.5M	2.7M	3.2M	3.3M	869.0K
Non-Operating Income (excl Interest)	(2.5M)	(2.7M)	(3.2M)	(1.7M)	(869.0K)
EBT (Pre-Tax Income)	13.0M	14.1M	16.8M	20.1M	20.7M
Income Tax Expense	2.3M	2.8M	2.9M	3.5M	4.2M
Bottom Line
Net Income	10.6M	11.3M	13.9M	16.6M	16.5M
Earnings from Cont. Ops	10.6M	11.3M	13.9M	16.6M	16.5M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	10.6M	11.3M	13.9M	16.6M	16.5M
Per Share
Basic EPS	$3.34	$3.48	$3.96	$4.57	$4.53
Diluted EPS	$3.34	$3.48	$3.96	$4.57	$4.52
Revenue Per Share	$10.98	$11.89	$11.68	$13.81	$14.37
Shares
Basic Shares Outstanding	3.2M	3.2M	3.5M	3.6M	3.6M
Diluted Shares Outstanding	3.2M	3.2M	3.5M	3.6M	3.6M
Profitability Metrics
EBITDA	14.9M	17.1M	19.6M	24.8M	27.7M
D&A	1.9M	3.0M	2.8M	6.4M	7.1M
EBIT	13.0M	14.1M	16.8M	18.4M	20.7M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026